Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutations
- PMID: 9797105
- DOI: 10.1016/s0015-0282(98)00247-7
Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutations
Abstract
Objective: To determine if the types of reproductive tract abnormalities linked to absence of the vas deferens varies with the cystic fibrosis transmembrane conductance regulator (CFTR) genotype.
Design: Prospective data gathering.
Setting: University infertility clinic.
Patient(s): Forty-six infertile men with absence of the scrotal vas deferens and no signs of cystic fibrosis.
Intervention(s): All had blood taken for CFTR gene analysis, 33 had scrotal ultrasounds, and 25 had transrectal ultrasounds.
Main outcome measure(s): The frequency of testicular, seminal vesicle, and ampullae of the vas deferens malformations was compared between subgroups of men with two, one, or no CFTR gene mutations.
Result(s): None (0 of 21) of the men with at least one CFTR gene mutations had normal ampullae of the vas or seminal vesicles bilaterally. Two (50%) of 4 men with no CFTR gene mutations had normal ampullae of the vas deferens bilaterally, and 50% had normal bilateral seminal vesicles (statistically significantly different). There was no correlation between testicular malformations and CFTR genotype.
Conclusion(s): This study indicates that the severity of the malformations in the testis is unrelated to the CFTR genotype, whereas the frequency and severity of wolffian duct malformations are related directly to the CFTR genotype.
Similar articles
-
Relation between the anatomical genital phenotype and cystic fibrosis transmembrane conductance regulator gene mutations in the absence of the vas deferens.Fertil Steril. 2002 May;77(5):889-96. doi: 10.1016/s0015-0282(02)02954-0. Fertil Steril. 2002. PMID: 12009340
-
Correlation between CFTR gene mutations in Iranian men with congenital absence of the vas deferens and anatomical genital phenotype.J Androl. 2008 Jan-Feb;29(1):35-40. doi: 10.2164/jandrol.107.002972. Epub 2007 Aug 1. J Androl. 2008. PMID: 17673436
-
Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counseling.Fertil Steril. 2000 Dec;74(6):1164-74. doi: 10.1016/s0015-0282(00)01625-3. Fertil Steril. 2000. PMID: 11119745
-
Genetic diseases of the seminal ducts.Biomed Pharmacother. 1998;52(5):197-203. doi: 10.1016/S0753-3322(98)80016-4. Biomed Pharmacother. 1998. PMID: 9755815 Review.
-
Congenital absence of the vas deferens: incomplete penetrance of cystic fibrosis gene mutations.J Urol. 1997 Nov;158(5):1794-8; discussion 1798-9. doi: 10.1016/s0022-5347(01)64131-4. J Urol. 1997. PMID: 9334604 Review.
Cited by
-
Assessing the Disease-Liability of Mutations in CFTR.Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a009480. doi: 10.1101/cshperspect.a009480. Cold Spring Harb Perspect Med. 2012. PMID: 23209179 Free PMC article.
-
A patient with 47, XYY mosaic karyotype and congenital absence of bilateral vas deferens: a case report and literature review.BMC Urol. 2022 Feb 2;22(1):16. doi: 10.1186/s12894-022-00965-1. BMC Urol. 2022. PMID: 35109852 Free PMC article. Review.
-
Exon 10 CFTR gene mutation in male infertility.Iran J Reprod Med. 2012 Jul;10(4):315-20. Iran J Reprod Med. 2012. PMID: 25246892 Free PMC article.
-
Cystic fibrosis transmembrane conductance regulator-related male infertility: Relevance of genetic testing & counselling in Indian population.Indian J Med Res. 2020 Dec;152(6):575-583. doi: 10.4103/ijmr.IJMR_906_18. Indian J Med Res. 2020. PMID: 34145097 Free PMC article.
-
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency.J Endocrinol Invest. 2004 Apr;27(4):370-4. doi: 10.1007/BF03351065. J Endocrinol Invest. 2004. PMID: 15233559
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical